Zevra Therapeutics, Inc.Zevra Therapeutics, Inc.Zevra Therapeutics, Inc.

Zevra Therapeutics, Inc.

No trades
See on Supercharts

Price target

20.430.000.00%
The 7 analysts offering 1 year price forecasts for ZVRA have a max estimate of — and a min estimate of —.

Analyst rating

Based on 8 analysts giving stock ratings to ZVRA in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


ZVRA EPS for the last quarter is −0.48 USD despite the estimation of −0.45 USD. In the next quarter EPS is expected to reach −0.41 USD. Track more of Zevra Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Zevra Therapeutics, Inc. revenue is expected to reach ‪4.87 M‬ USD. Check out Zevra Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, ZVRA price target is 20.43 USD with a max estimate of 25.00 USD and a min estimate of 15.00 USD. Check if this forecast comes true in a year, meanwhile watch Zevra Therapeutics, Inc. stock price chart and keep track of the current situation with ZVRA news and stock market news.
We've gathered opinions of 8 analysts rating ZVRA stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.